JP2008512987A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008512987A5 JP2008512987A5 JP2007522034A JP2007522034A JP2008512987A5 JP 2008512987 A5 JP2008512987 A5 JP 2008512987A5 JP 2007522034 A JP2007522034 A JP 2007522034A JP 2007522034 A JP2007522034 A JP 2007522034A JP 2008512987 A5 JP2008512987 A5 JP 2008512987A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- domain
- heavy chain
- binding
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 claims 17
- 102000036639 antigens Human genes 0.000 claims 17
- 108091007433 antigens Proteins 0.000 claims 17
- 238000000034 method Methods 0.000 claims 11
- 230000027455 binding Effects 0.000 claims 10
- 241000124008 Mammalia Species 0.000 claims 7
- 230000009261 transgenic effect Effects 0.000 claims 7
- 101150097493 D gene Proteins 0.000 claims 4
- 101150008942 J gene Proteins 0.000 claims 4
- 101150117115 V gene Proteins 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 241000282836 Camelus dromedarius Species 0.000 claims 2
- 230000009824 affinity maturation Effects 0.000 claims 2
- 239000012636 effector Substances 0.000 claims 2
- 108020001507 fusion proteins Proteins 0.000 claims 2
- 102000037865 fusion proteins Human genes 0.000 claims 2
- 230000003053 immunization Effects 0.000 claims 2
- 108020004999 messenger RNA Proteins 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 206010069754 Acquired gene mutation Diseases 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 108091026890 Coding region Proteins 0.000 claims 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- 238000010367 cloning Methods 0.000 claims 1
- 210000004408 hybridoma Anatomy 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 230000008707 rearrangement Effects 0.000 claims 1
- 230000037439 somatic mutation Effects 0.000 claims 1
- 230000009870 specific binding Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0416392A GB2416768A (en) | 2004-07-22 | 2004-07-22 | Heavy chain immunoglobulin complexes |
| GB0511881A GB0511881D0 (en) | 2005-06-10 | 2005-06-10 | Binding molecules |
| PCT/GB2005/002892 WO2006008548A2 (en) | 2004-07-22 | 2005-07-22 | Binding molecules |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011166561A Division JP5855381B2 (ja) | 2004-07-22 | 2011-07-29 | 結合分子 |
| JP2011166562A Division JP5888893B2 (ja) | 2004-07-22 | 2011-07-29 | 結合分子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008512987A JP2008512987A (ja) | 2008-05-01 |
| JP2008512987A5 true JP2008512987A5 (enExample) | 2008-11-13 |
Family
ID=35431831
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007522034A Pending JP2008512987A (ja) | 2004-07-22 | 2005-07-22 | 結合分子 |
| JP2011166562A Expired - Fee Related JP5888893B2 (ja) | 2004-07-22 | 2011-07-29 | 結合分子 |
| JP2011166561A Expired - Lifetime JP5855381B2 (ja) | 2004-07-22 | 2011-07-29 | 結合分子 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011166562A Expired - Fee Related JP5888893B2 (ja) | 2004-07-22 | 2011-07-29 | 結合分子 |
| JP2011166561A Expired - Lifetime JP5855381B2 (ja) | 2004-07-22 | 2011-07-29 | 結合分子 |
Country Status (21)
| Country | Link |
|---|---|
| US (7) | US20090285805A1 (enExample) |
| EP (6) | EP1978032A3 (enExample) |
| JP (3) | JP2008512987A (enExample) |
| KR (4) | KR101151957B1 (enExample) |
| CN (2) | CN102659940B (enExample) |
| AU (2) | AU2005263994B2 (enExample) |
| BR (1) | BRPI0513577A (enExample) |
| CA (1) | CA2580336C (enExample) |
| CY (2) | CY1115762T1 (enExample) |
| DK (3) | DK1776383T3 (enExample) |
| ES (3) | ES2440990T5 (enExample) |
| HU (1) | HUE034335T2 (enExample) |
| LT (1) | LT2311874T (enExample) |
| MX (2) | MX2007000921A (enExample) |
| PL (2) | PL2311874T3 (enExample) |
| PT (2) | PT2311874T (enExample) |
| RU (1) | RU2398882C2 (enExample) |
| SG (1) | SG188080A1 (enExample) |
| SI (2) | SI1776383T1 (enExample) |
| WO (1) | WO2006008548A2 (enExample) |
| ZA (3) | ZA200701186B (enExample) |
Families Citing this family (133)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7754208B2 (en) | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
| EP1978032A3 (en) * | 2004-07-22 | 2009-02-18 | Erasmus University Medical Center Rotterdam | Binding molecules |
| EP2295080A3 (en) | 2005-07-25 | 2011-06-22 | Emergent Product Development Seattle, LLC | B-cell reduction using CD37-specific and CD20-specific binding molecules |
| GB0601513D0 (en) * | 2006-01-25 | 2006-03-08 | Univ Erasmus Medical Ct | Binding molecules 3 |
| SG169348A1 (en) | 2006-01-25 | 2011-03-30 | Univ Erasmus Medical Ct | Generation of heavy-chain only antibodies in transgenic animals |
| GB0618345D0 (en) * | 2006-09-18 | 2006-10-25 | Univ Erasmus | Binding molecules |
| CN105837690A (zh) * | 2006-06-12 | 2016-08-10 | 新兴产品开发西雅图有限公司 | 具有效应功能的单链多价结合蛋白 |
| CA2673331A1 (en) | 2006-12-19 | 2008-06-26 | Ablynx N.V. | Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders |
| AU2007336243B2 (en) | 2006-12-19 | 2012-07-26 | Ablynx N.V. | Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders |
| GB0706628D0 (en) * | 2007-04-04 | 2007-05-16 | Univ Erasmus | Germ-line manipulation 1 |
| CA2688834C (en) | 2007-06-01 | 2020-01-07 | Ronald Buelow | Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies |
| WO2009013620A2 (en) * | 2007-06-11 | 2009-01-29 | Erasmus University Medical Center Rotterdam | Homologous recombination |
| AU2008270274B2 (en) | 2007-07-03 | 2012-06-28 | Ablynx N.V. | Providing improved immunoglobulin sequences by mutating CDR and/or FR positions |
| WO2009068631A1 (en) | 2007-11-27 | 2009-06-04 | Ablynx N.V. | Method for obtaining polypeptide constructs comprising two or more single domain antibodies |
| HRP20140604T1 (hr) | 2007-12-26 | 2014-09-12 | Biotest Ag | Sredstva koja djeluju na cd138 i njihova upotreba |
| BRPI0821417A2 (pt) | 2007-12-26 | 2015-06-16 | Biotest Ag | Método para diminuir a adesão de células de estroma a células tumorais que expressam cd138 em células tumorais de um indivíduo em necessidade do mesmo |
| JP5817034B2 (ja) | 2007-12-26 | 2015-11-18 | バイオテスト・アクチエンゲゼルシヤフト | Ｃｄ１３８を標的とする免疫複合体及びその使用 |
| AU2009235467A1 (en) | 2008-04-07 | 2009-10-15 | Ablynx Nv | Single variable domains against the Notch pathways |
| PT2132228E (pt) | 2008-04-11 | 2011-10-11 | Emergent Product Dev Seattle | Imunoterapia de cd37 e sua combinação com um quimioterápico bifuncional |
| NZ589036A (en) | 2008-05-16 | 2012-07-27 | Ablynx Nv | AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME |
| ES2436044T3 (es) | 2008-05-23 | 2013-12-26 | Ablexis, Llc | Procedimiento de generación de anticuerpos de dominio VL individual en animales transgénicos |
| HUE042053T2 (hu) | 2008-06-05 | 2019-06-28 | Ablynx Nv | Vírus burokfehérjéi elleni aminosav-szekvenciák és az azokat tartalmazó polipeptidek virális betegségek kezelésére |
| US20100136584A1 (en) * | 2008-09-22 | 2010-06-03 | Icb International, Inc. | Methods for using antibodies and analogs thereof |
| CA2747534C (en) | 2008-12-18 | 2020-08-18 | Erasmus University Medical Center Rotterdam | Non-human transgenic animals expressing humanised antibodies and use therof |
| AU2009329501B2 (en) | 2008-12-19 | 2015-11-26 | Ablynx N.V. | Genetic immunization for producing immunoglobulins against cell-associated antigens such as P2X7, CXCR7 or CXCR4 |
| WO2010079149A1 (de) | 2009-01-09 | 2010-07-15 | Ipk Gatersleben | Fusionsantikörper |
| GB0905023D0 (en) * | 2009-03-24 | 2009-05-06 | Univ Erasmus Medical Ct | Binding molecules |
| US9445581B2 (en) | 2012-03-28 | 2016-09-20 | Kymab Limited | Animal models and therapeutic molecules |
| CN102638971B (zh) | 2009-07-08 | 2015-10-07 | 科马布有限公司 | 动物模型及治疗分子 |
| DK2509409T3 (en) * | 2009-12-10 | 2016-11-14 | Regeneron Pharma | MICE, WHICH PRODUCES HEAVY CHAIN ANTIBODIES |
| HRP20251657T1 (hr) | 2009-12-14 | 2026-02-13 | Ablynx N.V. | Imunoglobulinska protutijela s jednostrukom varijabilnom domenom protiv ox40l, konstrukti i njihova terapijska upotreba |
| US9120855B2 (en) | 2010-02-10 | 2015-09-01 | Novartis Ag | Biologic compounds directed against death receptor 5 |
| CA2796633C (en) * | 2010-04-23 | 2020-10-27 | Genentech, Inc. | Production of heteromultimeric proteins |
| KR102306967B1 (ko) | 2010-08-02 | 2021-10-01 | 리제너론 파아마슈티컬스, 인크. | Ｖｌ 도메인을 포함하는 결합 단백질을 생성하는 마우스 |
| EA037063B1 (ru) | 2010-11-08 | 2021-02-01 | Аблинкс Н.В. | Cxcr2-связывающие полипептиды |
| WO2012122512A1 (en) * | 2011-03-10 | 2012-09-13 | Hco Antibody, Inc. | Recombinant production of mixtures of single chain antibodies |
| UA117218C2 (uk) | 2011-05-05 | 2018-07-10 | Мерк Патент Гмбх | Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f |
| US9433620B2 (en) | 2011-05-13 | 2016-09-06 | Cadila Healthcare Limited | Pharmaceutical compositions of lurasidone |
| AU2012311286B2 (en) | 2011-09-19 | 2018-07-26 | Kymab Limited | Antibodies, variable domains and chains tailored for human use |
| WO2013045916A1 (en) | 2011-09-26 | 2013-04-04 | Kymab Limited | Chimaeric surrogate light chains (slc) comprising human vpreb |
| US9253965B2 (en) | 2012-03-28 | 2016-02-09 | Kymab Limited | Animal models and therapeutic molecules |
| WO2013121440A1 (en) | 2012-02-13 | 2013-08-22 | Cadila Healthcare Limited | Process for preparing benzisothiazol-3-yl-peperazin-l-yl-methyl-cyclo hexyl-methanisoindol-1,3-dione and its intermediates |
| WO2013136186A2 (en) * | 2012-03-13 | 2013-09-19 | Novimmune S.A. | Readily isolated bispecific antibodies with native immunoglobulin format |
| US10251377B2 (en) | 2012-03-28 | 2019-04-09 | Kymab Limited | Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies |
| GB2502127A (en) * | 2012-05-17 | 2013-11-20 | Kymab Ltd | Multivalent antibodies and in vivo methods for their production |
| ES3065694T3 (en) | 2012-04-11 | 2026-05-07 | Us Health | Chimeric antigen receptors targeting b-cell maturation antigen |
| US9328174B2 (en) | 2012-05-09 | 2016-05-03 | Novartis Ag | Chemokine receptor binding polypeptides |
| SG11201504676VA (en) | 2012-12-14 | 2015-07-30 | Omt Inc | Polynucleotides encoding rodent antibodies with human idiotypes and animals comprising same |
| PL2967012T3 (pl) | 2013-03-14 | 2021-04-19 | Erasmus University Medical Center Rotterdam | Transgeniczne ssaki inne niż człowiek do wytwarzania przeciwciał |
| WO2014141192A1 (en) | 2013-03-15 | 2014-09-18 | Erasmus University Medical Center | Generation of heavy chain-only antibodies |
| US9788534B2 (en) | 2013-03-18 | 2017-10-17 | Kymab Limited | Animal models and therapeutic molecules |
| US9783593B2 (en) | 2013-05-02 | 2017-10-10 | Kymab Limited | Antibodies, variable domains and chains tailored for human use |
| US11707056B2 (en) | 2013-05-02 | 2023-07-25 | Kymab Limited | Animals, repertoires and methods |
| DK3041862T3 (da) * | 2013-09-05 | 2020-07-27 | Igm Biosciences Inc | Modificerede bispecifikke, penta- og hexavalente ig-m-antistoffer med konstant kæde |
| CA2925723A1 (en) | 2013-10-01 | 2015-04-09 | Kymab Limited | Animal models and therapeutic molecules |
| DK3105250T3 (da) | 2014-02-10 | 2020-09-28 | Igm Biosciences Inc | Multispecifikke iga-bindingsmolekyler |
| CN106255410B (zh) | 2014-03-21 | 2020-01-10 | 瑞泽恩制药公司 | 产生单结构域结合蛋白的非人动物 |
| KR102399028B1 (ko) * | 2014-03-21 | 2022-05-17 | 엑스-바디 인코포레이티드 | 이중-특이적 항원-결합 폴리펩티드 |
| CN106164092A (zh) | 2014-03-21 | 2016-11-23 | 瑞泽恩制药公司 | 表现不同结合特征的vl抗原结合蛋白 |
| JP6783224B2 (ja) | 2014-04-04 | 2020-11-11 | デル マー ファーマシューティカルズ | 肺の非小細胞癌腫及び卵巣癌を処置するためのジアンヒドロガラクチトール及びその類縁体又は誘導体の使用 |
| HRP20231139T1 (hr) | 2014-05-06 | 2024-01-05 | F. Hoffmann - La Roche Ag | Proizvodnja heteromultimernih proteina upotrebom stanica sisavaca |
| EP3461848B1 (en) | 2014-10-22 | 2023-10-11 | Crescendo Biologics Limited | Transgenic mice |
| US11111314B2 (en) | 2015-03-19 | 2021-09-07 | Regeneron Pharmaceuticals, Inc. | Non-human animals that select for light chain variable regions that bind antigen |
| HUE051165T2 (hu) | 2015-07-29 | 2021-03-01 | Allergan Inc | ANG-2 elleni, csak nehézláncot tartalmazó antitestek |
| CN105384825B (zh) | 2015-08-11 | 2018-06-01 | 南京传奇生物科技有限公司 | 一种基于单域抗体的双特异性嵌合抗原受体及其应用 |
| CA2992788A1 (en) | 2015-08-14 | 2017-02-23 | Allergan, Inc. | Heavy chain only antibodies to pdgf |
| KR102784293B1 (ko) | 2015-09-21 | 2025-03-20 | 압테보 리서치 앤드 디벨롭먼트 엘엘씨 | Cd3 결합 폴리펩타이드 |
| JP7628764B2 (ja) | 2015-09-29 | 2025-02-12 | アムジエン・インコーポレーテツド | Ａｓｇｒ阻害剤 |
| WO2018014260A1 (en) | 2016-07-20 | 2018-01-25 | Nanjing Legend Biotech Co., Ltd. | Multispecific antigen binding proteins and methods of use thereof |
| KR102512934B1 (ko) | 2016-08-10 | 2023-03-23 | 레전드 바이오테크 아일랜드 리미티드 | Bcma를 표적으로 하는 키메라 항원 수용체 및 이들의 이용 방법 |
| RU2762835C2 (ru) | 2016-08-24 | 2021-12-23 | Тенеобио, Инк. | Трансгенные животные, отличные от человека, продуцирующие модифицированные антитела, содержащие только тяжелые цепи |
| MY200988A (en) | 2016-09-14 | 2024-01-27 | Teneobio Inc | CD3 Binding Antibodies |
| WO2018068201A1 (en) | 2016-10-11 | 2018-04-19 | Nanjing Legend Biotech Co., Ltd. | Single-domain antibodies and variants thereof against ctla-4 |
| EP3332637A1 (en) * | 2016-12-09 | 2018-06-13 | Universitätsklinikum Hamburg-Eppendorf | Vhh-containing heavy chain antibody and production thereof |
| KR102745676B1 (ko) | 2016-12-21 | 2024-12-24 | 테네오바이오, 인코포레이티드 | 항-bcma 중쇄-단독 항체 |
| US12016313B2 (en) | 2017-01-19 | 2024-06-25 | Omniab Operations, Inc. | Human antibodies from transgenic rodents with multiple heavy chain immunoglobulin loci |
| JP2020516654A (ja) | 2017-04-13 | 2020-06-11 | センティ バイオサイエンシズ インコーポレイテッド | 組み合わせがん免疫療法 |
| WO2018237006A1 (en) | 2017-06-20 | 2018-12-27 | Teneoone, Inc. | Anti-bcma heavy chain-only antibodies |
| IL312322B2 (en) | 2017-06-20 | 2026-05-01 | Teneobio Inc | Antibodies against BCMA containing only heavy chains |
| RU2020112490A (ru) | 2017-09-13 | 2021-10-13 | Тенеобио, Инк. | Антитела из тяжелых цепей, связывающиеся с эктоферментами |
| AU2018391831B2 (en) | 2017-12-20 | 2022-08-04 | Harbour Biomed (Shanghai) Co., Ltd | Antibodies binding CTLA-4 and uses thereof |
| WO2019126756A1 (en) | 2017-12-22 | 2019-06-27 | Teneobio, Inc. | Heavy chain antibodies binding to cd22 |
| TW201930358A (zh) | 2017-12-28 | 2019-08-01 | 大陸商南京傳奇生物科技有限公司 | 針對ｔｉｇｉｔ之單域抗體及其變異體 |
| KR102839330B1 (ko) | 2018-01-15 | 2025-07-30 | 난징 레전드 바이오테크 씨오., 엘티디. | Pd-1에 대한 단일-도메인 항체 및 이의 변이체 |
| JP7346790B2 (ja) | 2018-03-30 | 2023-09-20 | ナンジン レジェンド バイオテック カンパニー，リミテッド | Ｌａｇ‐３に対する単一ドメイン抗体およびその使用 |
| KR102115300B1 (ko) | 2018-06-01 | 2020-05-26 | 재단법인 목암생명과학연구소 | 항체 라이브러리 및 이를 이용한 항체 스크리닝 방법 |
| EP4257602A3 (en) * | 2018-06-11 | 2023-12-27 | Aarhus Universitet | Single domain antibodies for complement regulation |
| WO2019240998A1 (en) * | 2018-06-13 | 2019-12-19 | Crystal Bioscience Inc. | Production of antibodies by modification of an autonomous heavy chain variable domain by gene conversion |
| BR112020024074A2 (pt) | 2018-07-20 | 2021-02-17 | Teneobio, Inc. | anticorpos de cadeia pesada com ligação a cd19 |
| GB2576914A (en) | 2018-09-06 | 2020-03-11 | Kymab Ltd | Antigen-binding molecules comprising unpaired variable domains produced in mammals |
| WO2020052542A1 (en) | 2018-09-10 | 2020-03-19 | Nanjing Legend Biotech Co., Ltd. | Single-domain antibodies against cll1 and constructs thereof |
| US11419898B2 (en) | 2018-10-17 | 2022-08-23 | Senti Biosciences, Inc. | Combinatorial cancer immunotherapy |
| CN112955467A (zh) | 2018-10-26 | 2021-06-11 | 特尼奥生物股份有限公司 | 与cd38结合的重链抗体 |
| WO2020169755A2 (en) | 2019-02-20 | 2020-08-27 | Harbour Antibodies Bv | Antibodies |
| CR20210500A (es) | 2019-04-05 | 2021-11-05 | Teneobio Inc | Anticuerpos de cadena pesada que se unen al psma |
| CN114206942A (zh) | 2019-06-07 | 2022-03-18 | 美国安进公司 | 双特异性结合构建体 |
| JP7665538B2 (ja) | 2019-06-14 | 2025-04-21 | テネオバイオ， インコーポレイテッド | Ｃｄ２２及びｃｄ３に結合する多重特異性重鎖抗体 |
| WO2021041920A1 (en) * | 2019-08-28 | 2021-03-04 | Senti Biosciences, Inc. | Combinatorial cancer immunotherapy |
| CN115023441A (zh) | 2019-12-18 | 2022-09-06 | 特诺福尔股份有限公司 | 与cd38结合的重链抗体 |
| GB202003632D0 (en) | 2020-03-12 | 2020-04-29 | Harbour Antibodies Bv | SARS-Cov-2 (SARS2, COVID-19) antibodies |
| WO2021222616A1 (en) | 2020-04-29 | 2021-11-04 | Teneobio, Inc. | Methods of treating multiple myeloma |
| WO2021222578A1 (en) | 2020-04-29 | 2021-11-04 | Teneobio, Inc. | Multispecific heavy chain antibodies with modified heavy chain constant regions |
| IL297601A (en) | 2020-04-29 | 2022-12-01 | Teneobio Inc | Multispecific heavy chain antibodies with modified heavy chain constant regions |
| AU2021283933A1 (en) | 2020-06-04 | 2023-01-05 | Amgen Inc. | Bispecific binding constructs |
| US20230242658A1 (en) * | 2020-06-30 | 2023-08-03 | Nona Biosciences (Suzhou) Co., Ltd. | 4-1bb-binding protein and use thereof |
| PE20230464A1 (es) | 2020-06-30 | 2023-03-14 | Teneobio Inc | Union de anticuerpos multiespecificos a bcma |
| JP2023535345A (ja) * | 2020-07-13 | 2023-08-17 | キソジ・バイオテクノロジー・インコーポレイテッド | 重鎖抗体を発現するトランスジェニック動物 |
| KR20230066386A (ko) | 2020-09-11 | 2023-05-15 | 리제너론 파마슈티칼스 인코포레이티드 | 항원 특이적 항체의 확인 및 제조 |
| GB202017555D0 (en) | 2020-11-06 | 2020-12-23 | Harbour Antibodies Bv | Antibody-conjugated nanoparticles |
| TW202233684A (zh) | 2020-11-18 | 2022-09-01 | 美商泰尼歐生物公司 | 結合於葉酸受體α之重鏈抗體 |
| WO2022120033A1 (en) | 2020-12-03 | 2022-06-09 | Amgen Inc. | Immunoglobuline constructs with multiple binding domains |
| EP4258865B1 (en) * | 2020-12-09 | 2025-09-03 | Trianni, Inc. | Heavy chain-only antibodies |
| AU2021400584A1 (en) | 2020-12-16 | 2023-06-29 | Regeneron Pharmaceuticals, Inc. | Mice expressing humanized fc alpha receptors |
| CN117321076A (zh) | 2021-02-19 | 2023-12-29 | 美国卫生及公众服务部代表 | 中和SARS-CoV-2的单结构域抗体 |
| JP2024507540A (ja) | 2021-02-25 | 2024-02-20 | テネオバイオ， インコーポレイテッド | 抗ｐｓｍａ抗体及びｃａｒ－ｔ構造 |
| CA3211142A1 (en) | 2021-02-26 | 2022-09-01 | Teneobio, Inc. | Anti-muc1-c antibodies and car-t structures |
| TW202304994A (zh) | 2021-04-02 | 2023-02-01 | 美商泰尼歐生物公司 | 促效性抗ｉｌ－２ｒ抗體及使用方法 |
| KR20230166090A (ko) | 2021-04-06 | 2023-12-06 | 테네오바이오, 인코포레이티드 | 항-cd19 항체 및 car-t 구조체 |
| KR20230171952A (ko) | 2021-04-16 | 2023-12-21 | 테네오바이오, 인코포레이티드 | 항-cd20 항체 및 car-t 구조 |
| CA3218564A1 (en) * | 2021-05-05 | 2022-11-10 | Leveragen, Inc. | Engineered non-human animals for producing antibodies |
| CN117651486A (zh) * | 2021-05-05 | 2024-03-05 | 利威瑞健股份有限公司 | 用于生产抗体的工程改造的非人动物 |
| WO2022271987A1 (en) | 2021-06-23 | 2022-12-29 | TeneoFour, Inc. | Anti-cd38 antibodies and epitopes of same |
| WO2023004197A1 (en) | 2021-07-23 | 2023-01-26 | Teneoten, Inc. | Heavy chain antibodies binding to hepatitis b surface antigen |
| WO2023036982A1 (en) | 2021-09-10 | 2023-03-16 | Harbour Antibodies Bv | Anti-sars2-s antibodies |
| GB202112935D0 (en) | 2021-09-10 | 2021-10-27 | Harbour Antibodies Bv | Sars-cov-2 (sars2, covid-19) heavy chain only antibodies |
| EP4598958A1 (en) | 2022-10-05 | 2025-08-13 | Amgen Inc. | Combination therapies comprising t-cell redirecting therapies and agonistic anti-il-2r antibodies or fragments thereof |
| WO2024083843A1 (en) | 2022-10-18 | 2024-04-25 | Confo Therapeutics N.V. | Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders |
| EP4512243A1 (en) | 2023-08-21 | 2025-02-26 | Kymab Limited | Binding molecules |
| WO2025217101A2 (en) | 2024-04-09 | 2025-10-16 | Amgen Inc. | Agonistic anti-il-2rbg heavy‑chain antibodies |
| GB202406483D0 (en) | 2024-05-09 | 2024-06-26 | Harbour Antibodies Bv | Crossing the blood brain barrier to treat diseases of the brain |
| WO2026030428A2 (en) | 2024-08-01 | 2026-02-05 | Regeneron Pharmaceuticals, Inc. | Prostate-specific antigen peptides and uses thereof |
| US20260123608A1 (en) | 2024-08-06 | 2026-05-07 | Regeneron Pharmaceuticals, Inc. | Non-human animals having modified immunoglobulin heavy chain constant region locus and uses thereof |
| WO2026096736A1 (en) | 2024-10-31 | 2026-05-07 | Regeneron Pharmaceuticals, Inc. | Rodents expressing humanized polymeric immunoglobulin receptor |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0045897A3 (en) | 1980-08-11 | 1982-03-24 | BAUSCH & LOMB INCORPORATED | Compact refraction instrument |
| AU612370B2 (en) | 1987-05-21 | 1991-07-11 | Micromet Ag | Targeted multifunctional proteins |
| EP0768377A1 (en) | 1988-09-02 | 1997-04-16 | Protein Engineering Corporation | Generation and selection of recombinant varied binding proteins |
| ES2052027T5 (es) | 1988-11-11 | 2005-04-16 | Medical Research Council | Clonacion de secuencias de dominio variable de inmunoglobulina. |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| US6150584A (en) * | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| ES2284161T3 (es) | 1990-01-12 | 2007-11-01 | Amgen Fremont Inc. | Generacion de anticuerpos xenogenicos. |
| US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US7041871B1 (en) | 1995-10-10 | 2006-05-09 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5877397A (en) | 1990-08-29 | 1999-03-02 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5843440A (en) | 1990-10-03 | 1998-12-01 | Redcell Canada, Inc. | Cellular and serum protein anchors for modulating pharmacokinetics |
| WO1992005801A1 (en) | 1990-10-04 | 1992-04-16 | University Of Virginia Alumni Patents Foundation | Primate erythrocyte bound monoclonal antibody heteropolymers |
| PT1621554E (pt) * | 1992-08-21 | 2009-07-13 | Univ Bruxelles | Imunoglobtainas desprovidas de cadeias leves |
| EP0739981A1 (en) | 1995-04-25 | 1996-10-30 | Vrije Universiteit Brussel | Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
| WO1998021355A1 (en) * | 1996-11-15 | 1998-05-22 | Life Technologies, Inc. | Mutants of green fluorescent protein |
| ATE549918T1 (de) | 1996-12-03 | 2012-04-15 | Amgen Fremont Inc | Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden |
| EP0954978B1 (en) * | 1998-03-12 | 2011-11-30 | VHsquared Limited | New products comprising inactivated yeasts or moulds provided with active antibodies |
| US7083950B2 (en) † | 1998-09-25 | 2006-08-01 | Regeneron Pharmaceuticals, Inc. | High affinity fusion proteins and therapeutic and diagnostic methods for use |
| EP1311530A4 (en) * | 2000-08-03 | 2004-10-06 | Wim-Van Schooten | PRODUCTION OF HUMANIZED ANTIBODIES IN TRANSGENIC ANIMALS |
| JP2004518407A (ja) | 2000-08-04 | 2004-06-24 | インサイト・ゲノミックス・インコーポレイテッド | 薬物代謝酵素 |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| WO2002079415A2 (en) * | 2001-03-30 | 2002-10-10 | Lexigen Pharmaceuticals Corp. | Reducing the immunogenicity of fusion proteins |
| US20030022240A1 (en) | 2001-04-17 | 2003-01-30 | Peizhi Luo | Generation and affinity maturation of antibody library in silico |
| GB0110029D0 (en) * | 2001-04-24 | 2001-06-13 | Grosveld Frank | Transgenic animal |
| WO2002100348A2 (en) | 2001-06-13 | 2002-12-19 | Genmab A/S | Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| GB0115256D0 (en) | 2001-06-21 | 2001-08-15 | Babraham Inst | Mouse light chain locus |
| AU2002319402B2 (en) * | 2001-06-28 | 2008-09-11 | Domantis Limited | Dual-specific ligand and its use |
| US6880232B2 (en) | 2001-09-26 | 2005-04-19 | Intel Corporation | Method of making an electrical inductor using a sacrificial electrode |
| JP2005289809A (ja) * | 2001-10-24 | 2005-10-20 | Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) | 突然変異重鎖抗体 |
| US6755339B2 (en) † | 2002-06-21 | 2004-06-29 | Delphi Technologies, Inc. | Fluxing apparatus for applying powdered flux |
| EP1600459A3 (en) * | 2002-06-28 | 2005-12-07 | Domantis Limited | Ligand |
| GB0218030D0 (en) | 2002-08-02 | 2002-09-11 | Minos Biosystems | Multi-submit protein production system |
| GB0228210D0 (en) * | 2002-12-03 | 2003-01-08 | Babraham Inst | Single chain antibodies |
| GB0230203D0 (en) | 2002-12-27 | 2003-02-05 | Domantis Ltd | Fc fusion |
| AU2004215125B2 (en) | 2003-02-26 | 2011-01-06 | Institute For Research In Biomedicine | Monoclonal antibody production by EBV transformation of B cells |
| WO2005070966A2 (en) † | 2004-01-16 | 2005-08-04 | Regeneron Pharmaceuticals, Inc. | Fusion polypeptides capable of activating receptors |
| US7785903B2 (en) | 2004-04-09 | 2010-08-31 | Genentech, Inc. | Variable domain library and uses |
| EP1978032A3 (en) | 2004-07-22 | 2009-02-18 | Erasmus University Medical Center Rotterdam | Binding molecules |
| CN101084317A (zh) | 2004-10-22 | 2007-12-05 | 人类多克隆治疗公司 | 对内源免疫球蛋白表达的抑制 |
| CA2595682A1 (en) | 2005-01-31 | 2006-08-03 | Ablynx N.V. | Method for generating variable domain sequences of heavy chain antibodies |
| MX2007014564A (es) | 2005-05-20 | 2008-02-07 | Ablynx Nv | Anticuerpos de vhh de dominio unico contra el factor de von willebrand. |
| SG169348A1 (en) * | 2006-01-25 | 2011-03-30 | Univ Erasmus Medical Ct | Generation of heavy-chain only antibodies in transgenic animals |
| GB0618345D0 (en) | 2006-09-18 | 2006-10-25 | Univ Erasmus | Binding molecules |
| CA2651567A1 (en) | 2006-05-09 | 2007-11-22 | Genentech, Inc. | Binding polypeptides with optimized scaffolds |
| US7731969B1 (en) | 2006-12-06 | 2010-06-08 | Neoclone Biotechnology International, Llc | Methods for developing and producing antigen-specific antibody-producing cells |
| CA2688834C (en) | 2007-06-01 | 2020-01-07 | Ronald Buelow | Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies |
| WO2009013620A2 (en) | 2007-06-11 | 2009-01-29 | Erasmus University Medical Center Rotterdam | Homologous recombination |
| GB0905023D0 (en) | 2009-03-24 | 2009-05-06 | Univ Erasmus Medical Ct | Binding molecules |
| DK2509409T3 (en) | 2009-12-10 | 2016-11-14 | Regeneron Pharma | MICE, WHICH PRODUCES HEAVY CHAIN ANTIBODIES |
| LT2738259T (lt) | 2011-02-25 | 2020-03-10 | Regeneron Pharmaceuticals, Inc. | Adam6 pelės |
| WO2012122512A1 (en) | 2011-03-10 | 2012-09-13 | Hco Antibody, Inc. | Recombinant production of mixtures of single chain antibodies |
| GB2502127A (en) | 2012-05-17 | 2013-11-20 | Kymab Ltd | Multivalent antibodies and in vivo methods for their production |
| SG11201504676VA (en) | 2012-12-14 | 2015-07-30 | Omt Inc | Polynucleotides encoding rodent antibodies with human idiotypes and animals comprising same |
| WO2014141192A1 (en) | 2013-03-15 | 2014-09-18 | Erasmus University Medical Center | Generation of heavy chain-only antibodies |
-
2005
- 2005-07-22 EP EP08075481A patent/EP1978032A3/en not_active Withdrawn
- 2005-07-22 ES ES07075586T patent/ES2440990T5/es not_active Expired - Lifetime
- 2005-07-22 EP EP05766644.8A patent/EP1776383B1/en not_active Revoked
- 2005-07-22 CN CN201210057668.0A patent/CN102659940B/zh not_active Expired - Lifetime
- 2005-07-22 KR KR1020107026625A patent/KR101151957B1/ko not_active Expired - Lifetime
- 2005-07-22 SI SI200531906T patent/SI1776383T1/sl unknown
- 2005-07-22 EP EP07075586.3A patent/EP1864998B2/en not_active Expired - Lifetime
- 2005-07-22 WO PCT/GB2005/002892 patent/WO2006008548A2/en not_active Ceased
- 2005-07-22 ES ES10179784.3T patent/ES2635497T3/es not_active Expired - Lifetime
- 2005-07-22 BR BRPI0513577-0A patent/BRPI0513577A/pt active Search and Examination
- 2005-07-22 SG SG2013004643A patent/SG188080A1/en unknown
- 2005-07-22 AU AU2005263994A patent/AU2005263994B2/en not_active Expired
- 2005-07-22 CN CN201210057684.XA patent/CN102659941B/zh not_active Expired - Lifetime
- 2005-07-22 DK DK05766644.8T patent/DK1776383T3/da active
- 2005-07-22 KR KR1020077004055A patent/KR101422286B1/ko not_active Expired - Fee Related
- 2005-07-22 CA CA2580336A patent/CA2580336C/en not_active Expired - Lifetime
- 2005-07-22 PL PL10179784T patent/PL2311874T3/pl unknown
- 2005-07-22 SI SI200532162T patent/SI2311874T1/sl unknown
- 2005-07-22 LT LTEP10179784.3T patent/LT2311874T/lt unknown
- 2005-07-22 PL PL05766644T patent/PL1776383T3/pl unknown
- 2005-07-22 PT PT101797843T patent/PT2311874T/pt unknown
- 2005-07-22 RU RU2007106728/13A patent/RU2398882C2/ru active
- 2005-07-22 US US11/658,361 patent/US20090285805A1/en not_active Abandoned
- 2005-07-22 ES ES05766644.8T patent/ES2523661T3/es not_active Expired - Lifetime
- 2005-07-22 PT PT57666448T patent/PT1776383E/pt unknown
- 2005-07-22 DK DK10179784.3T patent/DK2311874T3/en active
- 2005-07-22 KR KR1020117019563A patent/KR101457753B1/ko not_active Ceased
- 2005-07-22 HU HUE10179784A patent/HUE034335T2/en unknown
- 2005-07-22 KR KR1020127016031A patent/KR101443473B1/ko not_active Expired - Lifetime
- 2005-07-22 JP JP2007522034A patent/JP2008512987A/ja active Pending
- 2005-07-22 EP EP23218163.6A patent/EP4353819A3/en not_active Withdrawn
- 2005-07-22 EP EP17173113.6A patent/EP3272770B1/en not_active Expired - Lifetime
- 2005-07-22 DK DK07075586.3T patent/DK1864998T4/da active
- 2005-07-22 EP EP10179784.3A patent/EP2311874B1/en not_active Expired - Lifetime
- 2005-07-22 MX MX2007000921A patent/MX2007000921A/es active IP Right Grant
-
2007
- 2007-01-22 MX MX2012000436A patent/MX338603B/es unknown
- 2007-02-09 ZA ZA2007/01186A patent/ZA200701186B/en unknown
-
2008
- 2008-02-26 ZA ZA2008/01820A patent/ZA200801820B/en unknown
-
2009
- 2009-12-23 US US12/645,684 patent/US8921524B2/en active Active
- 2009-12-23 US US12/645,653 patent/US8921522B2/en active Active
-
2010
- 2010-08-24 AU AU2010212518A patent/AU2010212518B2/en not_active Expired
-
2011
- 2011-01-25 US US13/013,156 patent/US20110118444A1/en not_active Abandoned
- 2011-07-29 JP JP2011166562A patent/JP5888893B2/ja not_active Expired - Fee Related
- 2011-07-29 JP JP2011166561A patent/JP5855381B2/ja not_active Expired - Lifetime
-
2013
- 2013-02-25 ZA ZA2013/01416A patent/ZA201301416B/en unknown
- 2013-03-15 US US13/837,402 patent/US9353179B2/en not_active Expired - Lifetime
- 2013-03-15 US US13/837,520 patent/US9346877B2/en not_active Expired - Lifetime
-
2014
- 2014-11-17 CY CY20141100953T patent/CY1115762T1/el unknown
-
2017
- 2017-08-11 CY CY20171100869T patent/CY1119561T1/el unknown
-
2018
- 2018-04-16 US US15/953,622 patent/US10906970B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018138047A5 (enExample) | ||
| JP7171853B2 (ja) | 免疫グロブリン産生の増強 | |
| JP2015519055A5 (enExample) | ||
| EP3341485B1 (en) | Enhanced production of immunoglobulins | |
| CN104244709B (zh) | 共同轻链小鼠 | |
| JP2020530760A5 (enExample) | ||
| WO2014160202A4 (en) | Mice expressing a limited immunoglobulin light chain repertoire | |
| JP2013535213A5 (enExample) | ||
| JP2010529042A5 (enExample) | ||
| JP2015519076A5 (enExample) | ||
| JP2015525071A5 (enExample) | ||
| JP2014110814A5 (enExample) | ||
| RU2012128856A (ru) | Мыши, которые производят антитела, имеющие только тяжелую цепь | |
| JP2015510767A5 (enExample) | ||
| RU2021129958A (ru) | Отличные от человека животные со сконструированным локусом легкой лямбда-цепи иммуноглобулина | |
| JP2016512034A5 (enExample) | ||
| RU2007106728A (ru) | Связывающие молекулы | |
| WO2015042250A4 (en) | Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same | |
| JP2020508639A (ja) | Ｖｈｈ含有重鎖抗体およびその製造 | |
| JP7085992B2 (ja) | 共通軽鎖を有するトランスジェニックウサギ | |
| WO2022048604A1 (zh) | 一种非人哺乳动物或其子代的制备方法及其应用 | |
| CA3259663A1 (en) | ANIMAL MODELS AND THERAPEUTIC MOLECULES | |
| JP5904468B2 (ja) | ヒト型抗体を産生するｂ細胞の作製方法 | |
| CA3012833C (en) | Enhanced production of immunoglobulins |